The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage

Food and Chemical Toxicology

Volumn 46, Issue 4, 2008, Pages 1320-1326

  Kaindl, Ulrike ^a   Eyberg, Isgard ^a   Rohr Udilova, Natalia ^a   Heinzle, Christine ^a   Marian, Brigitte ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bioactive phenols; Colorectal cancer; Oxidative stress; Oxidized fatty acids; Quercetin; Resveratrol

Indexed keywords

CYCLOOXYGENASE 2; HYDROGEN PEROXIDE; HYDROPEROXIDE; LINOLEIC ACID HYDROPEROXIDE; QUERCETIN; RESVERATROL; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL GROWTH; CELL LOSS; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; COLORECTAL ADENOMA; CONTROLLED STUDY; DRUG MECHANISM; FOOD INTAKE; HUMAN; HUMAN CELL; OXIDATIVE STRESS;

ANTIOXIDANTS; CELL COUNT; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DIET; DINOPROSTONE; HT29 CELLS; HUMANS; HYDROGEN PEROXIDE; OXIDANTS; OXIDATIVE STRESS; QUERCETIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 39149143709     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.09.002     Document Type: Article

References (42)

1. Banerjee S., Bueso-Ramos C., and Aggarwal B.B. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 62 (2002) 4945-4954
2. Bartsch H., and Nair J. New DNA-based biomarkers for oxidative stress and cancer chemoprevention studies. Eur. J. Cancer 36 (2000) 1229-1234
3. Bednar W., Holzmann K., and Marian B. Assessing 12(S)-lipoxygenase inhibitory activity using colorectal cancer cells overexpressing the enzyme. Food Chem. Toxicol. 45 (2007) 508-514
4. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
5. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
6. Deschner E.E., Ruperto J., Wong G., and Newmark H.L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 12 (1991) 1193-1196
7. Deschner E.E., Ruperto J.F., Wong G.Y., and Newmark H.L. The effect of dietary quercetin and rutin on AOM-induced acute colonic epithelial abnormalities in mice fed a high-fat diet. Nutr. Cancer 20 (1993) 199-204
8. Hansel B., Giral P., Nobecourt E., Chantepie S., Bruckert E., Chapman M.J., and Kontush A. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J. Clin. Endocrinol. Metab. 89 (2004) 4963-4971
9. Horvath Z., Saiko P., Illmer C., Madlener S., Hoechtl T., Bauer W., Erker T., Jaeger W., Fritzer-Szekeres M., and Szekeres T. Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. Exp. Hematol. 33 (2005) 329-335
10. Huang S.M., Wu C.H., and Yen G.C. Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs. Mol. Nutr. Food Res. 50 (2006) 1129-1139
11. Joe A.K., Liu H., Suzui M., Vural M.E., Xiao D., and Weinstein I.B. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8 (2002) 893-903
12. Jurek D., Udilova N., Jozkowicz A., Nohl H., Marian B., and Schulte-Hermann R. Dietary lipid hydroperoxides induce expression of vascular endothelial growth factor (VEGF) in human colorectal tumor cells. Faseb J. 19 (2005) 97-99
13. Lee K.W., and Lee H.J. The roles of polyphenols in cancer chemoprevention. Biofactors 26 (2006) 105-121
14. Leiro J., Alvarez E., Arranz J.A., Laguna R., Uriarte E., and Orallo F. Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J. Leukoc. Biol. 75 (2004) 1156-1165
15. Lewis C.E., and Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66 (2006) 605-612
16. Mahmoud N.N., Carothers A.M., Grunberger D., Bilinski R.T., Churchill M.R., Martucci C., Newmark H.L., and Bertagnolli M.M. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21 (2000) 921-927 10.1093/carcin/21.5.921
17. Martin A.R., Villegas I., Sanchez-Hidalgo M., and de la Lastra C.A. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Brit. J. Pharmacol. 147 (2006) 873-885
18. Martinez J., and Moreno J.J. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. Biochem. Pharmacol. 59 (2000) 865-870
19. Masferrer J.L., Koki A., and Seibert K. COX-2 inhibitors. A new class of antiangiogenic agents. Ann. NY Acad. Sci. 889 (1999) 84-86
20. Mouria M., Gukovskaya A.S., Jung Y., Buechler P., Hines O.J., Reber H.A., and Pandol S.J. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer 98 (2002) 761-769
21. Murias M., Handler N., Erker T., Pleban K., Ecker G., Saiko P., Szekeres T., and Jager W. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg. Med. Chem. 12 (2004) 5571-5578
22. Nie D., and Honn K.V. Cyclooxygenase, lipoxygenase and tumor angiogenesis. Cell Mol. Life Sci. 59 (2002) 799-807
23. Nie D., and Honn K.V. Eicosanoid regulation of angiogenesis in tumors. Semin. Thromb. Hemost. 30 (2004) 119-125
24. O'Prey J., Brown J., Fleming J., and Harrison P.R. Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochem. Pharmacol. 66 (2003) 2075-2088
25. Pereira M.A., Grubbs C.J., Barnes L.H., Li H., Olson G.R., Eto I., Juliana M., Whitaker L.M., Kelloff G.J., Steele V.E., and Lubet R.A. Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17 (1996) 1305-1311 10.1093/carcin/17.6.1305
26. Pool-Zobel B.L., Adlercreutz H., Glei M., Liegibel U.M., Sittlingon J., Rowland I., Wahala K., and Rechkemmer G. Isoflavonoids and lignans have different potentials to modulate oxidative genetic damage in human colon cells. Carcinogenesis 21 (2000) 1247-1252
27. Renaud S., and de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339 (1992) 1523-1526
28. Richter M., Ebermann R., and Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr. Cancer 34 (1999) 88-99
29. Richter M., Weiss M., Weinberger I., Furstenberger G., and Marian B. Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors. Carcinogenesis 22 (2001) 17-25
30. Richter M., Jurek D., Wrba F., Kaserer K., Wurzer G., Karner-Hanusch J., and Marian B. Cells obtained from colorectal microadenomas mirror early premalignant growth patterns in vitro. Eur. J. Cancer 38 (2002) 1937-1945
31. Schmid K., Nair J., Winde G., Velic I., and Bartsch H. Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients. Int. J. Cancer 87 (2000) 1-4
32. Seno H., Oshima M., Ishikawa T.O., Oshima H., Takaku K., Chiba T., Narumiya S., and Taketo M.M. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res. 62 (2002) 506-511
33. Sexton E., Van Themsche C., LeBlanc K., Parent S., Lemoine P., and Asselin E. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol. Cancer 5 (2006) 45
34. Sies H., Stahl W., and Sevanian A. Nutritional, dietary and postprandial oxidative stress. J. Nutr. 135 (2005) 969-972
35. Sonoshita M., Takaku K., Sasaki N., Sugimoto Y., Ushikubi F., Narumiya S., Oshima M., and Taketo M.M. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice. Nat. Med. 7 (2001) 1048-1051
36. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 3 (2003) 768-780
37. Surh Y.J., Hurh Y.J., Kang J.Y., Lee E., Kong G., and Lee S.J. Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140 (1999) 1-10
38. Tessitore L., Davit A., Sarotto I., and Caderni G. Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21CIP expression. Carcinogenesis 21 (2000) 1619-1622
39. Udilova N., Jurek D., Marian B., Gille L., Schulte-Hermann R., and Nohl H. Induction of lipid peroxidation in biomembranes by dietary oil components. Food Chem. Toxicol. 41 (2003) 1481-1489
40. Veeriah S., Hofmann T., Glei M., Dietrich H., Will F., Schreier P., Knaup B., and Pool-Zobel B.L. Apple polyphenols and products formed in the gut differently inhibit survival of human cell lines derived from colon adenoma (LT97) and carcinoma (HT29). J. Agric. Food Chem. 55 (2007) 2892-2900
41. Volate S.R., Davenport D.M., Muga S.J., and Wargovich M.J. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26 (2005) 1450-1456 10.1093/carcin/bgi089
42. Willson J.K., Bittner G.N., Oberley T.D., Meisner L.F., and Weese J.L. Cell culture of human colon adenomas and carcinomas. Cancer Res. 47 (1987) 2704-2713